Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength (Descending) SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00069-0546-30 00069-0546 Talazoparib Talzenna 0.5 mg/1 Chemotherapy Enzyme Inhibitor PARP Oral April 17, 2024 In Use
68788-8626-01 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
68788-8626-03 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
68788-8626-06 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
68788-8626-09 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 9, 2024 In Use
42658-0008-01 42658-0008 Dactinomycin Dactinomycin 0.5 mg/1 Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous May 8, 2024 In Use
72865-0140-30 72865-0140 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral March 9, 2020 In Use
72865-0140-90 72865-0140 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral March 9, 2020 In Use
72578-0019-06 72578-0019 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral April 15, 2019 In Use
72578-0019-16 72578-0019 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral April 15, 2019 In Use

Found 10,000 results in 13 milliseconds — Export these results